These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3067480)

  • 1. Prediction of ovulation with the assessment of LH and the E1G/P2G ratio in urinary samples.
    Baviera G; Carroccio G; Scurria L; Pizzi V; Scarselli G
    Acta Eur Fertil; 1988; 19(3):139-42. PubMed ID: 3067480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
    Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
    Adekunle AO; Collins WP; Whitehead MI
    Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
    Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
    J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of the dual-analyte enzyme immunoassay for ovulation timing.
    Lenton EA; King H; Johnson J; Amos S
    Hum Reprod; 1989 May; 4(4):378-80. PubMed ID: 2663906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between indicators of the fertile period of the menstrual cycle and ultrasonically-determined ovulation].
    Croce P; Quarenghi A; Montanari G; Barbato M; Pravettoni G; Bertolotti G
    Minerva Endocrinol; 1989; 14(3):147-52. PubMed ID: 2622425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prediction and/or detection of ovulation by means of urinary steroid assays.
    Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
    Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personal hormone monitoring for contraception.
    Bonnar J; Flynn A; Freundl G; Kirkman R; Royston R; Snowden R
    Br J Fam Plann; 1999 Jan; 24(4):128-34. PubMed ID: 10023097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
    Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
    Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
    Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
    Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of over-the-counter (OTC) assays for pregnanediol-3-glucuronide and estrone-B,D-glucuronide.
    Bahar I
    Prog Clin Biol Res; 1988; 285():139-51. PubMed ID: 3231643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.
    Merlo AB; Farinati Z; Quiroga S; Nagle CA; Carril LM; Lahoz M; Mendizabal AF
    Int J Fertil; 1984; 29(3):189-93. PubMed ID: 6152260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validation of the Billings ovulation method by laboratory research and field trials.
    Billings JJ
    Acta Eur Fertil; 1991; 22(1):9-15. PubMed ID: 1746210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovulation prediction and detection.
    Collins WP
    IPPF Med Bull; 1982 Oct; 16(5):1-2. PubMed ID: 12311795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-prediction of ovulation using a urinary luteinizing hormone test.
    Corson SL
    J Reprod Med; 1986 Aug; 31(8 Suppl):760-3. PubMed ID: 3761282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements.
    Behre HM; Kuhlage J; Gassner C; Sonntag B; Schem C; Schneider HP; Nieschlag E
    Hum Reprod; 2000 Dec; 15(12):2478-82. PubMed ID: 11098014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Day-Specific Serum LH, Estradiol, and Progesterone with Mira
    Usala SJ; Vineyard DD; Kastis M; Trindade AA; Gill HS
    Medicina (Kaunas); 2024 Jul; 60(8):. PubMed ID: 39202489
    [No Abstract]   [Full Text] [Related]  

  • 19. The OVEIA Dual Analyte assay--a new method for profiling the menstrual cycle.
    Baker TS
    Prog Clin Biol Res; 1988; 285():101-18. PubMed ID: 3231642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting menstrual migraine with a home-use fertility monitor.
    MacGregor EA; Frith A; Ellis J; Aspinall L
    Neurology; 2005 Feb; 64(3):561-3. PubMed ID: 15699399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.